About Familial hyperaldosteronism type II
Familial hyperaldosteronism type II is a rare disease catalogued by Orphanet (ORPHA:404). It is associated with the CLCN2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Familial hyperaldosteronism type II trials.
Search ClinicalTrials.gov for "Familial hyperaldosteronism type II" or filter by Orphanet code ORPHA:404 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Familial hyperaldosteronism type II trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Familial hyperaldosteronism type II. Updated daily.